Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01344616 · ClinicalTrials.gov registry record · Phase 2
Reducing Preterm Births in Underserved Pregnant Women
A Phase 2 study of Preterm Birth and Low Birth Weight <2500 Grams, sponsored by PHCC.
- Completed
- Registry status
- Phase 2
- Development phase
- 482
- Enrollment target
- 1
- Study location
NCT01344616 is a Phase 2 study of Preterm Birth and Low Birth Weight <2500 Grams that has completed, run by PHCC. The registered enrollment target is 482 participants, below the 4,617-participant average among 37 other Preterm Birth trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01344616, a Phase 2 study of Preterm Birth and Low Birth Weight <2500 Grams, has completed, sponsored by PHCC.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 482 participants
- Enrollment target
- 1
- Study location
Study Summary
Timely screening and management of modifiable conditions can reduce preterm births, yet providing effective prenatal risk management systems to meet the unique needs of medically underserved populations is complex. If the proposed system proves to be effective in reducing preterm births it can improve maternal and child quality of life as well as reduce the economic burden of preterm births in the U.S.
Conditions Studied
Interventions
- BEHAVIORAL lifestyle support
Study Locations (1)
Colorado
- PHCC LP - Pueblo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 482 participants |
| Start Date | 2010-08 |
| Est. Completion | 2013-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01344616
The ClinicalTrials.gov registry entry for NCT01344616 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 482 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,617-participant average among 37 other Preterm Birth trials with a reported enrollment target (90% lower). The listed sponsor is PHCC, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Preterm Birth appearing as the primary indexed condition, and to 1 intervention - of which lifestyle support is the first listed.
NCT01344616 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT01344616 about?
NCT01344616 is a clinical study titled "Reducing Preterm Births in Underserved Pregnant Women". Timely screening and management of modifiable conditions can reduce preterm births, yet providing effective prenatal risk management systems to meet the unique needs of medically underserved populations is complex. If the proposed system proves to be effective in reducing preterm births it can impro...
What is the current status of trial NCT01344616?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 482 participants. The study started on 2010-08. Estimated completion is 2013-10.
What conditions does trial NCT01344616 study?
This clinical trial studies the following conditions: Preterm Birth, Low Birth Weight <2500 Grams, Verylow Birthweight <1500 Grams.
What interventions are being tested in trial NCT01344616?
The interventions under investigation include: lifestyle support (BEHAVIORAL).
Who is sponsoring clinical trial NCT01344616?
This trial is sponsored by PHCC, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01344616 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preterm Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effect of Sulfasalazine on CRH Levels in Pregnant Women
RECRUITING · Phase 2
-
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
ACTIVE NOT RECRUITING · Phase 2
-
Transition From Donor Milk: a Feasibility Study
RECRUITING · NA
-
Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)
RECRUITING · Phase 4
-
Reducing Pregnancy Risks: The Mastery Lifestyle Intervention
RECRUITING · NA
-
Daily Aspirin vs Split Dosing in High-risk Pregnancies (DASH)
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.